期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

帕金森病神经炎性反应的再认识 被引量：1

Rethinking of neuroinflammation in Parkinson disease
原文传递
导出
摘要 神经炎性反应伴随着帕金森病的疾病进程，小胶质细胞和星形胶质细胞的持续炎症加重疾病进程，现在大多数研究均针对小胶质细胞和星形胶质细胞为中心展开。近年来对帕金森病神经炎性反应的研究又有了一些新的认识，现综述如下。
作者 方鑫
机构地区 南昌大学第一附属医院神经内科
出处 《神经疾病与精神卫生》 2013年第4期424-425,共2页 Journal of Neuroscience and Mental Health
基金 江西省卫生厅科技计划项目（20133047）
关键词 综述文献 帕金森病 炎性反应 胶质细胞 Review Parkinson disease Neuroinflammation reaction~ Gliocyte
分类号 R654.1 [医药卫生—外科学]
  • 相关文献

参考文献16

  • 1Glass CK,Saijo K,Winner B,et al.Mechanisms underlying inflammation in neurodegeneration[J].Cell,2010,140 (6):918-934.
  • 2Farooqui T,Farooqui AA.Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease[J].Parkinsons Dis,2011,2011:247 467.
  • 3van Dijk KD,Teunissen CE,Drukarch B,et al.Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease:a pathogenetically based approach[J].Neurobiol Dis,2010,39 (3):229-241.
  • 4Long-Smith CM,Sullivan AM,Nolan YM.The influence of microglia on the pathogenesis of Parkinson's disease[J].Prog Neurobiol,2009,89(3):277-287.
  • 5von Bernhardi R,Tichauer JE,Eugenin J.Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders[J].J Neuro Chem,2010,112 (5): 1 099-1 114.
  • 6Lee HJ,Suk JE,Patrick C,et al.Direct transfer of alphasynuclein from neuron to astroglia causes inflammatory responses in synucleinopathies[J].J Biol Chem,2010,285 (12) :9 262-9 272.
  • 7Lucin KM,Wyss-Coray T.Immune activation in brain aging and neurodegeneration,too much or too little?[J].Neuron,2009,64(1):110-122.
  • 8孙圣刚,黎钢,曹学兵,童萼塘.帕金森病与炎症反应关系研究进展[J].中华神经科杂志,2003,36(6):401-403. 被引量：24
  • 9吕风月,李军泉,张海燕,许秋岩,徐群渊,赵咏梅.脑室内注射脂多糖致脑内炎症大鼠模型黑质多巴胺能神经元与胶质细胞的早期变化[J].中国老年学杂志,2009,29(1):1-4. 被引量：6
  • 10Graeber MB,Streit WJ.Microglia:biology and pathology[J].Acta Neuropathol,2010,119(1):89-105.

二级参考文献8

  • 1Orr CF, Rowe DB, Halliday GM. An inflammatory review of Parkinson's disease[ J]. Prog Neurobiol, 2002 ; 68 ( 5 ) : 32540.
  • 2Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson's disease[J]. Br J Pharmacol, 2007; 150(8) :963-76.
  • 3Castano A, Herrera AJ, Cano J,et al. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system[J]. J Neurochem, 1998; 70(4) :1584-92.
  • 4Herrera A J, Castano A, Venero JL, et al. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system[ J ~. Neurobiol Dis, 2000 ;7 ( 4 ) :429- 47.
  • 5McGeer PL, ltagaki S, Boyes BE, et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains[ J]. Neurology, 1988 ; 38 : 1255-91.
  • 6Liu Bin, Gao HM, Hong JS. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation[ J]. Environ Health Perspec, 2003 ; 111 ( 8 ) : 1065- 73.
  • 7Femandes A, Silva RF, Falcao AS,et al. Cytokine production, glutamate release and cell death in rat cultured astrocytes treated with unconjugated bilirubin and LPS[J]. J Neuroimmunol, 2004; 153(1-2) :64-75.
  • 8李军泉,王元身,孙晓红,张进禄,徐群渊.脑内炎症反应对大鼠黑质多巴胺能神经元长时程毒性作用的研究[J].解剖学报,2008,39(3):350-354. 被引量：6

共引文献28

同被引文献14

  • 1Devine MJ, Gwinn K, Singleton A, et al. Parkinson’s diseaseand a - synuclein expression [J]. Mov Disord, 2011,26 (12):2 160-2 168.
  • 2Yu R, Liu B, Wang L,et al. Enhanced functional connectivitybetween putamen and supplementary motor area in Parkinson’sdisease patients[J]. PLoS One,2013,8(3) :e59 717.
  • 3Wasner G,Deuschl G. Pains in Parkinson disease - manysyndromes under one umbrella[J]. Nat Rev Neurol,2012,8(5):284-294.
  • 4Neikrug AB,Liu L,Avanzino JA. et al. Continuous positiveairway pressure improves sleep and daytime sleepiness in pa-tients with Parkinson disease and sleep apnea[J]. Sleep,2014,37(1):177-185.
  • 5Daniel SE,Lees AJ. Parkinson’s Disease Society Brain Bank,London: overview and research[J]. J Neural Transm,1993,39(Suppl) ;165 -172.
  • 6Dubow JS. Autonomic dysfunction in Parkinson’s disease[J].Dis Mon,2007,53(5) :265-274.
  • 7MaetzlerW,Apel A, Langkamp M, et al. Comparable au-toantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson’s disease patients and controls[J]. PLoS One,2014,9(2) :e88 604.
  • 8Koziorowski D, Tomasiuk R, Szlufik S,et al. Inflammatorycytokines and NT - proCNP in Parkinson's disease patients[J]. Cytokine,2012,60(3) :762 -766.
  • 9Whitton PS. Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson’s disease[J]. Curr OpinInvestig Drugs,2010.11(7) :788 -794.
  • 10Yu SY,Sun L, Liu Z,et al. Sleep disorders in Parkinson'sdisease: clinical features, iron metabolism and related mecha-nism[J]. PLoS One,2013,8(12) :e82 924.

引证文献1

二级引证文献5

神经疾病与精神卫生
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部